Work

Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement

Year: 2007

Type: article

Source: Mayo Clinic Proceedings

DOI: 10.1016/s0025-6196(11)61029-x

Authors: Angela Dispenzieri, S. Vincent Rajkumar, Morie A. Gertz, Martha Q. Lacy, Robert A. Kyle, Philip R. Greipp, Thomas E. Witzig, John A. Lust, Stephen J. Russell, Suzanne R. Hayman, Shaji Kumar, Steven R. Zeldenrust, Rafael Fonseca, P. Leif Bergsagel, Craig B. Reeder, A. Keith Stewart, Vivek Roy, Robert J. Dalton

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Biogen, Celgene, National Institutes of Health, Genentech, Takeda Oncology, National Cancer Institute

Awards: G1234102995, G2018127191, G243382380, Virotherapy for Relapsed Refractory Multiple Myeloma, Chromosomal Abnormalities in Myeloma as Detected by FISH, G3071120689, Angiogenesis and thalidomide therapy in multiple myeloma, SPORE in Multiple Myeloma, G6317171496, G7585679282, Prevalence and Progression of Monoclonal Gammopathies, Studies on Monoclonal Gammopathies, Treatment of Early Stage Multiple Myeloma, G8687299782, G918026202

OpenAlex ID: W2013123944

FWCI: 17.78

Cites: 212

Cited by: 224

Related to: 10